Literature DB >> 9793795

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

A D Blann1, C N McCollum.   

Abstract

Inflammatory mediators, such as tumor necrosis factor alpha (TNF), may be important in the pathogenesis of atherosclerosis. Interactions between TNF and its target cell(s) requires the presence of specific receptors on the latter. Plasma levels of the two soluble forms of these receptors (tumor necrosis factor receptors, (sTNFr)) and TNF itself were measured by ELISA in 20 patients with peripheral vascular disease (PVD), 20 survivors of a myocardial infarction, and 20 age and sex matched controls. Levels of the p55 variant of the sTNFr were unchanged but levels of the p75 variant were increased in both groups of patients (ANOVA both P < 0.01). TNF was also raised in both groups of patients (both P < 0.05) but levels did not correlate with either sTNFr. In atherosclerosis, increased levels of p75 sTNFr may be further evidence of inappropriate leukocyte activation but unlikely to modulate the effect of free plasma TNF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793795     DOI: 10.1023/a:1022346010304

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  Effects of tumour necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells.

Authors:  E M Paleolog; M A Carew; J D Pearson
Journal:  Int J Radiat Biol       Date:  1991 Jul-Aug       Impact factor: 2.694

2.  Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers.

Authors:  E G Langeler; W Fiers; V W van Hinsbergh
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

3.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

4.  von Willebrand factor is an acute phase reactant in man.

Authors:  B E Pottinger; R C Read; E M Paleolog; P G Higgins; J D Pearson
Journal:  Thromb Res       Date:  1989-02-15       Impact factor: 3.944

5.  Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms.

Authors:  M H Thornhill; S M Wellicome; D L Mahiouz; J S Lanchbury; U Kyan-Aung; D O Haskard
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

6.  A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

Authors:  H Engelmann; D Aderka; M Rubinstein; D Rotman; D Wallach
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

7.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

8.  Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy.

Authors:  M W Boehme; R Waldherr; A Kist; S Riedl; R Walter-Kirst; J Kempeni; U Raeth
Journal:  Eur J Clin Invest       Date:  1996-05       Impact factor: 4.686

9.  Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques.

Authors:  P G Tipping; W W Hancock
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.

Authors:  B Robaye; R Mosselmans; W Fiers; J E Dumont; P Galand
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

View more
  8 in total

1.  Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis.

Authors:  H Bruunsgaard; P Skinhøj; A N Pedersen; M Schroll; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.

Authors:  C L Welch; S Bretschger; N Latib; M Bezouevski; Y Guo; N Pleskac; C P Liang; C Barlow; H Dansky; J L Breslow; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

Review 4.  Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction.

Authors:  U N Das
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 5.  Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.

Authors:  Nicola Maruotti; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2014-11-27       Impact factor: 3.984

6.  Tumor necrosis factor receptor levels are associated with carotid atherosclerosis.

Authors:  Mitchell S Elkind; Jianfeng Cheng; Bernadette Boden-Albala; Tanja Rundek; Joyce Thomas; Hong Chen; LeRoy E Rabbani; Ralph L Sacco
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

7.  Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan study.

Authors:  Yasuyoshi Takei; Marco R Di Tullio; Shunichi Homma; Bernadette Boden-Albala; Tatjana Rundek; Ralph L Sacco; Grace Berry; Rui Liu; Zhezhen Jin; Kazuo Eguchi; Mitchell S V Elkind
Journal:  Am J Hypertens       Date:  2009-04-23       Impact factor: 2.689

8.  Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.

Authors:  Renate B Schnabel; Xiaoyan Yin; Martin G Larson; Jennifer F Yamamoto; João D Fontes; Sekar Kathiresan; Jian Rong; Daniel Levy; John F Keaney; Thomas J Wang; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-02       Impact factor: 8.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.